Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast CancerAnastasia A. Ionkina, Jennifer R. Diamond|Frontiers in Oncology|2017Cited by 22